|4Apr 28, 9:02 PM ET

Marsh Martha H. 4

4 · Edwards Lifesciences Corp · Filed Apr 28, 2022

Insider Transaction Report

Form 4
Period: 2022-04-28
Transactions
  • Exercise/Conversion

    Common Stock

    2022-04-28$25.99/sh+28,722$746,43655,499 total
  • Sale

    Common Stock

    2022-04-28$108.09/sh28,722$3,104,56426,777 total
  • Exercise/Conversion

    Director Stock Option (Right to Acquire)

    2022-04-2828,7220 total
    Exercise: $25.99From: 2016-11-19Exp: 2022-11-18Common Stock (28,722 underlying)
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $108.00 to $108.55. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    doc4.xmlPrimary